Peptide Synthesis Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Peptide Synthesis Market to 2027 - Global Analysis and Forecasts By Product (Reagents, Synthesizer and Chromatography), Therapeutic Area (Cardiovascular Disorder, Cancer, Respiratory Disorder, Metabolic Disorder, Dermatology and Others), End-user (Pharmaceutical & Biotechnological Companies, Contract Research Organizations (CROs), Academic & Research Institutes, and Other End Users), and Geography

Report Code: TIPBT00002596 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Peptides are active and very specific drug substances. The peptides have higher variety of their biological functions, due to which they are used in a broad range of therapeutic areas. Moreover, they are progressively entering drug development paths as potential active pharmaceutical ingredients because of their large chemical space, high specificity, biological activity, relative ease of synthesis, ready availability, and low toxicity. These are used in the treatment of the various diseases such as cancer, cardiovascular diseases, respiratory disorders, and others.

The peptide synthesis market is anticipated to grow with a significant rate in the coming years, owing to the factors such as increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and development of advanced peptide synthesizers. Moreover, increase in developments in the emerging nations, funds provided by the government bodies offer growth opportunities in the peptide synthesis market.

The "Global Peptide Synthesis Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global peptide synthesis market trend. The report aims to provide an overview of global peptide synthesis market with detailed market segmentation by product, therapeutic area, end user, and geography. The global peptide synthesis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the peptide synthesis market.

The global peptide synthesis market is segmented on the basis of product, therapeutic area, and end user. The product segment includes reagents, synthesizer and chromatography. Based on therapeutic area, the peptide synthesis market is segmented as, cardiovascular disorder, cancer, respiratory disorder, metabolic disorder, dermatology and others. Based on end user, the market is classified as, pharmaceutical & biotechnological companies, contract research organizations (CROs), academic & research institutes, and other end users.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global peptide synthesis market based on product, therapeutic area, and end user. It also provides market size and forecast till 2027 for overall Peptide Synthesis market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The peptide synthesis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to hold the maximum share of peptide synthesis market, owing to the rising research and development activities in the life science and biotechnology sectors, manufacturers aiming on offering the products on the basis of the specific and unique requirements, and presence of major key players and developments in the healthcare and use of peptide therapeutics as a highly potent drug used in oncology and hormonal treatment in the region. However, Asia Pacific is also expected to grow at a significant growth rate due to increased investments in R&D by various players and government bodies, manufacturers are aiming on providing well-established technologies to ensure sustainable and strong revenue growth from this region.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key peptide synthesis manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Merck KGaA, GenScript, Aapptec, Biotage, CEM Corporation, Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical, Sanofi, and AstraZeneca Plc. among others.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. PEPTIDE SYNTHESIS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Peptide Synthesis Market - By Product
3.2.2. Peptide Synthesis Market - By Therapeutic Area
3.2.3. Peptide Synthesis Market - By End User
3.2.4. Peptide Synthesis Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America - PEST Analysis

4. PEPTIDE SYNTHESIS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. PEPTIDE SYNTHESIS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL PEPTIDE SYNTHESIS MARKET OVERVIEW
5.2. GLOBAL PEPTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS

6. PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. REAGENTS MARKET
6.3.1. Overview
6.3.2. Reagents Market Revenue Forecasts and Analysis (US$ Mn)
6.4. SYNTHESIZER MARKET
6.4.1. Overview
6.4.2. Synthesizer Market Revenue Forecasts and Analysis (US$ Mn)
6.5. CHROMATOGRAPHY MARKET
6.5.1. Overview
6.5.2. Chromatography Market Revenue Forecasts and Analysis (US$ Mn)

7. PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - BY THERAPEUTIC AREA
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. CARDIOVASCULAR DISORDER MARKET
7.3.1. Overview
7.3.2. Cardiovascular Disorder Market Revenue Forecasts and Analysis (US$ Mn)
7.4. CANCER MARKET
7.4.1. Overview
7.4.2. Cancer Market Revenue Forecasts and Analysis (US$ Mn)
7.5. RESPIRATORY DISORDER MARKET
7.5.1. Overview
7.5.2. Respiratory Disorder Market Revenue Forecasts and Analysis (US$ Mn)
7.6. METABOLIC DISORDER MARKET
7.6.1. Overview
7.6.2. Metabolic Disorder Market Revenue Forecasts and Analysis (US$ Mn)
7.7. DERMATOLOGY MARKET
7.7.1. Overview
7.7.2. Dermatology Market Revenue Forecasts and Analysis (US$ Mn)
7.8. OTHERS MARKET
7.8.1. Overview
7.8.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

8. PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES MARKET
8.3.1. Overview
8.3.2. Pharmaceutical & Biotechnological Companies Market Revenue Forecasts and Analysis (US$ Mn)
8.4. CONTRACT RESEARCH ORGANIZATIONS (CROS) MARKET
8.4.1. Overview
8.4.2. Contract Research Organizations (CROs) Market Revenue Forecasts and Analysis (US$ Mn)
8.5. ACADEMIC & RESEARCH INSTITUTES MARKET
8.5.1. Overview
8.5.2. Academic & Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
8.6. OTHER END USERS MARKET
8.6.1. Overview
8.6.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)


9. NORTH AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA PEPTIDE SYNTHESIS MARKET OVERVIEW
9.2. NORTH AMERICA PEPTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
9.4. NORTH AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY THERAPEUTIC AREA (US$ MN)
9.5. NORTH AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. US Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
9.7.3. US Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. Canada Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
9.8.3. Canada Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.9.2. Mexico Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
9.9.3. Mexico Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)


10. EUROPE PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE PEPTIDE SYNTHESIS MARKET OVERVIEW
10.2. EUROPE PEPTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
10.4. EUROPE PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY THERAPEUTIC AREA (US$ MN)
10.5. EUROPE PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. FRANCE MARKET OVERVIEW
10.7.1. France Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. France Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
10.7.3. France Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. Germany Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
10.8.3. Germany Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. UK MARKET OVERVIEW
10.9.1. UK Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.9.2. UK Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
10.9.3. UK Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

11. ASIA PACIFIC PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC PEPTIDE SYNTHESIS MARKET OVERVIEW
11.2. ASIA PACIFIC PEPTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. ASIA PACIFIC PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY THERAPEUTIC AREA (US$ MN)
11.5. ASIA PACIFIC PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. CHINA MARKET OVERVIEW
11.7.1. China Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. China Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
11.7.3. China Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. India Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
11.8.3. India Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. JAPAN MARKET OVERVIEW
11.9.1. Japan Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.2. Japan Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
11.9.3. Japan Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

12. MIDDLE EAST AND AFRICA (MEA) PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) PEPTIDE SYNTHESIS MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) PEPTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA) PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY THERAPEUTIC AREA (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA) PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA) PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.7.2. South Africa Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
12.7.3. South Africa Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.8.2. Saudi Arabia Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
12.8.3. Saudi Arabia Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.2. UAE Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutics (US$ Mn)
12.9.3. UAE Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

13. SOUTH AND CENTRAL AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA PEPTIDE SYNTHESIS MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA PEPTIDE SYNTHESIS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY THERAPEUTIC AREA (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA PEPTIDE SYNTHESIS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Peptide Synthesis Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.7.2. Brazil Peptide Synthesis Market Revenue Forecasts and Analysis - By Therapeutic Area (US$ Mn)
13.7.3. Brazil Peptide Synthesis Market Revenue Forecasts and Analysis - By End User (US$ Mn)

14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions

15. PEPTIDE SYNTHESIS MARKET, KEY COMPANY PROFILES
15.1. MERCK KGAA
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. GENSCRIPT
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. AAPPTEC
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. SWOT Analysis
15.3.6. Key Developments

15.4. BIOTAGE
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. CEM CORPORATION
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. ELI LILLY AND COMPANY
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. PFIZER INC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. TEVA PHARMACEUTICAL
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. SANOFI
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. ASTRAZENECA PLC
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. SWOT Analysis
15.10.6. Key Developments

16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies

1. Merck KGaA
2. GenScript
3. Aapptec
4. Biotage
5. CEM Corporation
6. Eli Lilly and Company
7. Pfizer Inc.
8. Teva Pharmaceutical
9. Sanofi
10. AstraZeneca Plc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book